头颈癌手术加速康复外科方案:系统评价与Meta分析
该系统评价与Meta分析检索PubMed、Embase和Web of Science数据库,纳入9项比较性观察研究,评估加速康复外科(ERAS)方案用于头颈癌手术(伴或不伴微血管重建)的效果;Meta分析显示ERAS组住院时间平均减少1.37天(95%CI 0.77-1.96;I²=0%;P<.00001),吗啡毫克当量标准化均数差降低0.72(95%CI 0.26-1.18;I²=82%;P=.002);作者结论认为实施ERAS方案可减少住院时间和阿片类药物使用,但需进一步高质量前瞻性研究。
要点
- ERAS组住院时间较非ERAS对照组平均减少1.37天(95%CI 0.77-1.96;I²=0%;P<.00001)。
- ERAS组吗啡毫克当量标准化均数差较对照组降低0.72(95%CI 0.26-1.18;I²=82%;P=.002)。
- 纳入研究质量中等,MINORS评分中位数18.5(范围13.5-21.5)。
核心结论
- 实施ERAS方案可减少住院时间和阿片类药物使用,但尚需进一步高质量前瞻性研究,尤其需按头颈癌手术类型对结局进行分层分析。
研究设计与样本
- 系统评价与Meta分析,遵循PRISMA指南,检索PubMed、Embase和Web of Science数据库,由2名研究者独立筛选摘要,纳入比较性观察研究,排除动物研究、病例报告和病例系列。
- 初检557篇文章经标题和/或摘要审查,30篇进入全文筛选,最终9篇符合定性合成标准。
主要发现
- ERAS组住院时间较非ERAS对照组平均减少1.37天(95%CI 0.77-1.96;I²=0%;P<.00001)。
- ERAS组吗啡毫克当量标准化均数差较对照组降低0.72(95%CI 0.26-1.18;I²=82%;P=.002)。
- 纳入研究质量中等,MINORS评分中位数18.5(范围13.5-21.5)。
局限性
- 作者指出尚需进一步高质量前瞻性研究,尤其需按头颈癌手术类型对结局进行分层分析。
- 吗啡毫克当量合并分析异质性I²=82%。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Enhanced recovery after surgery (ERAS) protocols aim to optimize the pre-, intra-, and postoperative care of patients to improve surgery outcomes, reduce complications, decrease length of stay, and more. We aim to perform a systematic review and meta-analysis of ERAS protocols for head and neck cancer surgery with or without microvascular reconstruction. DATA SOURCES: PubMed, Embase, and Web of Science databases were queried, and abstracts were screened independently by 2 investigators. REVIEW METHODS: This review was conducted in accordance with the PRISMA guidelines. We included comparative observational studies but excluded animal studies, case reports, and case series. RESULTS: Of 557 articles initially reviewed by title and/or abstract, we identified 30 for full-text screening, and 9 met the criteria for qualitative synthesis. Meta-analysis of length of stay revealed a mean decrease of 1.37 days (95% CI, 0.77-1.96; I2 = 0%; P < .00001) with the ERAS group as compared with non-ERAS controls. The standardized mean difference of the morphine milligram equivalent was 0.72 lower (95% CI, 0.26-1.18; I2 = 82%; P = .002) in the ERAS group vs controls. The quality of studies was moderate with a median MINORS score of 18.5 (range, 13.5-21.5). CONCLUSION: Implementation of ERAS protocols can lead to decreases in length of stay and opioid drug utilization. However, further high-quality prospective studies of ERAS protocols are needed, especially with stratified analysis of outcomes based on the type of head and neck cancer surgery.
引用
- Kattar N, Wang SX, Trojan JD, et al. Enhanced Recovery After Surgery Protocols for Head and Neck Cancer: Systematic Review and Meta-analysis. Otolaryngol Head Neck Surg. 2023. PMID: 35290105. doi:10.1177/01945998221082541
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。